146 related articles for article (PubMed ID: 34776509)
1. DMPK hypermethylation in sperm cells of myotonic dystrophy type 1 patients.
Yanovsky-Dagan S; Cohen E; Megalli P; Altarescu G; Schonberger O; Eldar-Geva T; Epsztejn-Litman S; Eiges R
Eur J Hum Genet; 2022 Aug; 30(8):980-983. PubMed ID: 34776509
[TBL] [Abstract][Full Text] [Related]
2. CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy.
Barbé L; Lanni S; López-Castel A; Franck S; Spits C; Keymolen K; Seneca S; Tomé S; Miron I; Letourneau J; Liang M; Choufani S; Weksberg R; Wilson MD; Sedlacek Z; Gagnon C; Musova Z; Chitayat D; Shannon P; Mathieu J; Sermon K; Pearson CE
Am J Hum Genet; 2017 Mar; 100(3):488-505. PubMed ID: 28257691
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of congenital myotonic dystrophy.
Lanni S; Pearson CE
Neurobiol Dis; 2019 Dec; 132():104533. PubMed ID: 31326502
[TBL] [Abstract][Full Text] [Related]
4. MSH2 knock-down shows CTG repeat stability and concomitant upstream demethylation at the DMPK locus in myotonic dystrophy type 1 human embryonic stem cells.
Franck S; Barbé L; Ardui S; De Vlaeminck Y; Allemeersch J; Dziedzicka D; Spits C; Vanroye F; Hilven P; Duqué G; Vermeesch JR; Gheldof A; Sermon K
Hum Mol Genet; 2021 Jan; 29(21):3566-3577. PubMed ID: 33242073
[TBL] [Abstract][Full Text] [Related]
5. Stable Longitudinal Methylation Levels at the CpG Sites Flanking the CTG Repeat of
Hildonen M; Knak KL; Dunø M; Vissing J; Tümer Z
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32823742
[TBL] [Abstract][Full Text] [Related]
6.
Visconti VV; Macrì E; D'Apice MR; Centofanti F; Massa R; Novelli G; Botta A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373276
[TBL] [Abstract][Full Text] [Related]
7. CTG Expansion in the DMPK Gene: Semen Quality Assessment and Outcome of Preimplantation Genetic Diagnosis.
Puy V; Mayeur A; Levy A; Hesters L; Raad J; Monnot S; Steffann J; Frydman N
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31996899
[TBL] [Abstract][Full Text] [Related]
8. Uncovering the Role of Hypermethylation by CTG Expansion in Myotonic Dystrophy Type 1 Using Mutant Human Embryonic Stem Cells.
Yanovsky-Dagan S; Avitzour M; Altarescu G; Renbaum P; Eldar-Geva T; Schonberger O; Mitrani-Rosenbaum S; Levy-Lahad E; Birnbaum RY; Gepstein L; Epsztejn-Litman S; Eiges R
Stem Cell Reports; 2015 Aug; 5(2):221-31. PubMed ID: 26190529
[TBL] [Abstract][Full Text] [Related]
9. Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1.
Peric S; Pesovic J; Savic-Pavicevic D; Rakocevic Stojanovic V; Meola G
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008780
[TBL] [Abstract][Full Text] [Related]
10. Fuchs' Endothelial Corneal Dystrophy and RNA Foci in Patients With Myotonic Dystrophy.
Mootha VV; Hansen B; Rong Z; Mammen PP; Zhou Z; Xing C; Gong X
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4579-4585. PubMed ID: 28886202
[TBL] [Abstract][Full Text] [Related]
11. High Resolution Analysis of
Rasmussen A; Hildonen M; Vissing J; Duno M; Tümer Z; Birkedal U
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741732
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1.
Salvatori S; Fanin M; Trevisan CP; Furlan S; Reddy S; Nagy JI; Angelini C
Neurol Sci; 2005 Oct; 26(4):235-42. PubMed ID: 16193250
[TBL] [Abstract][Full Text] [Related]
13. Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
Winkler NS; Milone M; Martinez-Thompson JM; Raja H; Aleff RA; Patel SV; Fautsch MP; Wieben ED; Baratz KH
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3053-3057. PubMed ID: 30025114
[TBL] [Abstract][Full Text] [Related]
14. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.
Furling D; Lam le T; Agbulut O; Butler-Browne GS; Morris GE
Am J Pathol; 2003 Mar; 162(3):1001-9. PubMed ID: 12598332
[TBL] [Abstract][Full Text] [Related]
15. Myotonic dystrophy type 1 (DM1) clinical subtypes and CTCF site methylation status flanking the CTG expansion are mutant allele length-dependent.
Morales F; Corrales E; Zhang B; Vásquez M; Santamaría-Ulloa C; Quesada H; Sirito M; Estecio MR; Monckton DG; Krahe R
Hum Mol Genet; 2021 Dec; 31(2):262-274. PubMed ID: 34432028
[TBL] [Abstract][Full Text] [Related]
16. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.
Santoro M; Masciullo M; Silvestri G; Novelli G; Botta A
Clin Genet; 2017 Oct; 92(4):355-364. PubMed ID: 27991661
[TBL] [Abstract][Full Text] [Related]
17. Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program.
Johnson NE; Butterfield RJ; Mayne K; Newcomb T; Imburgia C; Dunn D; Duval B; Feldkamp ML; Weiss RB
Neurology; 2021 Feb; 96(7):e1045-e1053. PubMed ID: 33472919
[TBL] [Abstract][Full Text] [Related]
18. Study of expression of genes potentially responsible for reduced fitness in patients with myotonic dystrophy type 1 and identification of new biomarkers of testicular function.
Ergoli M; Venditti M; Picillo E; Minucci S; Politano L
Mol Reprod Dev; 2020 Jan; 87(1):45-52. PubMed ID: 31840338
[TBL] [Abstract][Full Text] [Related]
19. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes.
Overend G; Légaré C; Mathieu J; Bouchard L; Gagnon C; Monckton DG
Hum Mol Genet; 2019 Jul; 28(13):2245-2254. PubMed ID: 31220271
[TBL] [Abstract][Full Text] [Related]
20. Generation of three myotonic dystrophy type 1 patient iPSC lines (CBRCULi018-A, CBRCULi019-A, CBRCULi020-A) derived from lymphoblastoid cell lines for disease modelling and therapeutic research.
Pierre M; Jauvin D; Puymirat J; Boutjdir M; Chahine M
Stem Cell Res; 2024 Apr; 76():103375. PubMed ID: 38490135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
